Clinical Trial Update: SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs

View source ↗

Summary

Clinical trial update for SCOPE-CLI (NCT04710563) sponsored by Yale University studying outcomes for patients with endangered limbs due to Peripheral Arterial D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Snippet

Sponsor: Yale University | Conditions: Peripheral Arterial Disease | Status: ACTIVE_NOT_RECRUITING